Market revenue in 2023 | USD 22.2 million |
Market revenue in 2030 | USD 59.5 million |
Growth rate | 15.1% (CAGR from 2023 to 2030) |
Largest segment | Radiofrequency ablation |
Fastest growing segment | Other Ablation Technologies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 34.68% in 2023. Horizon Databook has segmented the India tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
India is one of the fastest-growing markets for tumor ablation owing to the heavy burden of chronic diseases, including cancer, rising government initiatives to screen & diagnose cancer, and benefits of tumor ablation procedures.
The standardized incidence rate for every 100,000 individuals was 18, while the prevalence rate over 5 years, across all age groups, and was 42.82 per 100,000 individuals. According to the National Cancer Registry Programme, cervical cancers were the most frequent among women.
Cervical cancer contributed to 6% to 29% of all cancer cases in women in India. These factors are expected to drive the market growth. However, medium to high costs associated with tumor ablation surgery may limit market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the India tumor ablation market , including forecasts for subscribers. This country databook contains high-level insights into India tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account